Potential for personalised application of inhaled nitric oxide in COVID-19 pneumonia
Benjamin Garfield, Charles McFadyen, Charlotte Briar, Caroline Bleakley, Aikaterini Vlachou, Melissa Baldwin, Nick Lees, Susanna Price, Stephane Ledot, Colm McCabe, S John Wort, Brijesh V Patel, Laura C Price, Benjamin Garfield, Charles McFadyen, Charlotte Briar, Caroline Bleakley, Aikaterini Vlachou, Melissa Baldwin, Nick Lees, Susanna Price, Stephane Ledot, Colm McCabe, S John Wort, Brijesh V Patel, Laura C Price
No abstract availableKeywords: ARDS; COVID-19; inhaled nitric oxide; pulmonary hypertension; right ventricular dysfunction.
Figures
References
- World Health Organisation. Available from: ; Accessed 25 Oct 2020.
- Phua J., Weng L., Ling L. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med. 2020;8:506–517.
- Gebistorf F., Karam O., Wetterslev J. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults. Cochrane Database Syst Rev. 2016;2016:CD002787.
- Hedenstierna G., Chen L., Hedenstierna M. Treatment of COVID-19 by inhaled NO to reduce shunt? Am J Respir Crit Care Med. 2020;202:618.
- Patel B.V., Arachchillage D.J., Ridge C.A. Pulmonary angiopathy in severe COVID-19: physiologic, imaging and hematologic observations. Am J Respir Crit Care Med. 2020;202:690–699.
- Longobardo A., Montanari C., Shulman R. Inhaled nitric oxide minimally improves oxygenation in COVID-19 related acute respiratory distress syndrome. Br J Anaesth. 2020 doi: 10.1016/j.bja.2020.10.011. Advance Access published on October 14.
- Force A.D.T., Ranieri V.M., Rubenfeld G.D. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307:2526–2533.
- Trachsel D., McCrindle B.W., Nakagawa S. Oxygenation index predicts outcome in children with acute hypoxemic respiratory failure. Am J Respir Crit Care Med. 2005;172:206–211.
- Nuckton T.J., Alonso J.A., Kallet R.H. Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome. N Engl J Med. 2002;346:1281–1286.
- Charron C., Repesse X., Bouferrache K. PaCO2 and alveolar dead space are more relevant than PaO2/FiO2 ratio in monitoring the respiratory response to prone position in ARDS patients: a physiological study. Crit Care. 2011;15:R175.
- Ferrari M., Santini A., Protti A. Inhaled nitric oxide in mechanically ventilated patients with COVID-19. J Crit Care. 2020;60:159–160.
- Benedetto M., Romano R., Baca G. Inhaled nitric oxide in cardiac surgery: evidence or tradition? Nitric Oxide. 2015;49:67–79.
- Schmid E.R., Bürki C., Engel M.H. Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery. Anesth Analg. 1999;89:1108–1115.
- Argulian E., Sud K., Vogel B. Right ventricular dilation in hospitalized patients with COVID-19 infection. JACC Cardiovasc Imaging. 2020;13:2459–2461.
- Ridge C.A., Desai S., Jeyin N. Dual energy computed tomography pulmonary angiography (DECTPA) depicts early vascular disturbances in severe COVID-19 pneumonia. Radiol Cardiothorac Imaging. 2020;2 doi: 10.1148/ryct.2020200428.
Source: PubMed